Login

Journal Image
Current Pharmaceutical Biotechnology
ISSN (Print): 1389-2010
ISSN (Online): 1873-4316
VOLUME: 9
ISSUE: 3
DOI: 10.2174/138920108784567308      Price:  $58









A Novel Biological Actions Acquired by Ribonuclease Through Oligomerization

img
Author(s): M. Libonati, G. Gotte and F. Vottariello
Pages 200-209 (10)
Abstract:
After a short introduction with some examples of cytotoxic ribonucleases, the importance of natural or artificial dimerization (oligomerization) as a way for a ribonuclease to acquire novel functional properties has been pointed out. In particular, the role of the three dimensional domain swapping mechanism in bovine pancreatic ribonuclease A oligomerization, as well as its impact for the acquisition of novel biological functions (among which a remarkable antitumor action) by the enzyme protein in oligomeric form have been discussed. Finally, the structural and functional features that could explain why oligomeric ribonuclease A becomes able to display a cytotoxic activity, and the possible use and limits of the three dimensional domain-swapped oligomers of ribonuclease A as anticancer therapeutic agents have been described and discussed.
Keywords:
RNase A, RNase A dimers, RNase A oligomers, Cytotoxicity, RNase cytotoxicity, Cytotoxicity of oligomeric RNase A, Antitumor therapy, 3D domain swapping
Affiliation:
Dipartimento di Scienze Morfologico-Biomediche, Sezione di Chimica Biologica, Istituti Biologici, Strada Le Grazie 8, I-37134 Verona, Italy.